医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ResMed Debuts MaskSelector, a Digital Tool for Remote CPAP Mask Fittings

2020年05月18日 PM10:00
このエントリーをはてなブックマークに追加


 

SAN DIEGO

ResMed (NYSE: RMD, ASX: RMD) has launched ResMed MaskSelector, a digital tool to make remote patient mask selection and sizing easier and more effective, helping patients receive the care they need from home.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200518005130/en/

ResMed MaskSelector - Patient welcome screen (Photo: Business Wire)

ResMed MaskSelector – Patient welcome screen (Photo: Business Wire)

ResMed MaskSelector creates personalized ResMed mask recommendations based on a patient’s sleep attributes and facial measurements. An HME can provide a HIPAA-compliant single-use link via text or email to a patient, who then answers a brief questionnaire and enters three facial measurements into the ResMed MaskSelector portal. Based on the patient’s responses, the tool will recommend one of ResMed’s industry-leading masks, along with options for alternate ResMed mask models and sizes.

HMEs say they need better remote capabilities to fit and select masks for patients during the COVID-19 pandemic, according to a recent survey of roughly 300 clinicians. Fifty-five percent of respondents stated mask selection was the area in which they either experienced or expected the most challenges with remote setup patients. Additionally, 54 percent said they were likely to continue offering remote CPAP setups to their new patients in the future.

“ResMed MaskSelector is the digital health technology solution to HMEs’ challenge of finding the right mask for each patient when they can’t physically see them due to physical distancing,” said Jim Hollingshead, ResMed Sleep president. “Mask fit and comfort is key to a new CPAP user’s therapy success, and this online tool helps clinicians find the best option for their patients – today and long after this pandemic ends.”

MaskSelector is available starting today to most HMEs in the U.S. It is being offered at no charge now through December 31 to help HMEs serve their patients during the COVID-19 public health emergency. Interested HMEs should contact their ResMed Solutions Consultant or Sales representative.

Visit ResMed.com/MaskSelector to learn more.

About ResMed

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200518005130/en/

CONTACT

For media

Jayme Rubenstein

+1 858.836.6798

news@resmed.com

For investors

Amy Wakeham

+1 858.836.5000

investorrelations@resmed.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial
  • Samyang Biopharm USA Announces Establishment of “Samyang CRS Award in Honor of Sung Wan Kim” for Biomedical Research
  • EUSA Pharma、COVID-19関連急性呼吸窮迫症候群の入院患者でシルツキシマブを検討する第3相臨床試験をFDAが承認と発表
  • EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer
  • HitGen and Morphic Extend Drug Discovery Research Collaboration